tiprankstipranks
Editas Medicine upgraded to Outperform from In Line at Evercore ISI
The Fly

Editas Medicine upgraded to Outperform from In Line at Evercore ISI

Evercore ISI upgraded Editas Medicine (EDIT) to Outperform from In Line with a $7 price target

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App